The announcement fell on Tuesday: The University of Oxford has decided to suspend trials on children of its anti-Covid-19 vaccine, developed in partnership with the AstraZeneca laboratory. A decision linked to certain concerns …
While recent studies have proven its effectiveness against severe forms of Covid-19, Oxford decides to suspend trials of the AstraZeneca vaccine on children. A decision that would be linked to certain concerns regarding the formation of blood clots in vaccinated adults. In a press release, the university explains that it has chosen to suspend this trial until the British Medicines Agency (MHRA) gives its final opinion on these potential side effects.
“Although there are no safety concerns in the pediatric clinical trial, we are awaiting further information from the MHRA on its review of rare cases of thrombosis that have been reported in adults, before proceeding with further investigation. ‘other vaccinations as part of the trial,’ the university explains. “No safety problem has been identified in the process”, according to the same source. At the heart of a great controversy, the use of the AstraZenaca vaccine has been suspended in about fifteen European countries.
Suspected of being the cause of blood clots in some people, the vaccine has been in the crosshairs in recent weeks. After the death of seven people in the United Kingdom from blood clots, several countries have given in to panic by suspending their vaccination campaigns with AstraZeneca or by limiting it to the elderly such as Germany, France, the Netherlands. Bas or even Canada. This while the WHO remains on its positive position with regard to this vaccine, “the benefits of which far outweigh the risks” as the experts of the world organization affirm.
Get the latest news delivered to your inbox
Follow us on social media networks